Drug Trial Radar · NCT04129931
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
Last checked: Nov 20, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
950
Actual
Start
Dec 19, 2019
Primary completion
Feb 19, 2025
Study completion Mar 19, 2025
Sponsor
- Lead sponsor
- University of North Carolina, Chapel HillAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- Oct 17, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate several interventions given to participants with severe asthma. Interventions are administered in a crossover manner with 16-week treatment periods followed by 8 to 16 week washout.
Conditions
- Asthma
Interventions
MCTDrug
Mix 2-5 packets daily into liquid or food for 16 weeks.
ClazakizumabDrug
12.5 mg subcutaneous injection given once every 4 weeks for 16 weeks. Lab driven dose reductions will be made based on safety lab data. If criteria are met for dose reduction, the participant will be reduced to a 6.25 mg dose.
Broncho-VaxomDrug
7 mg taken orally once a day, on an empty stomach, for 16 weeks
Imatinib MesylateDrug
Two 100 mg tablets orally once a day with a meal and an 8 oz glass of water for 2 weeks. If the drug is well tolerated, participants will titrate up to four 100 mg tablets once a day with a meal and an 8 oz glass of water for 14 weeks. Safety labs will be collected at each study visit to monitor the tolerability of each participant.
CavosonstatDrug
50 mg capsule orally twice a day for 16 weeks.
PlaceboOther
MCT Matching Placebo: MCT matching placebo packets. Mix 2-5 packets daily into liquid or food for 16 weeks. Clazakizumab Matching Placebo: 12.5 mg subcutaneous saline injection given once every 4 weeks for 16 weeks. Broncho-Vaxom Matching Placebo: 7 mg matching placebo taken orally once a day on an empty stomach for 16 weeks Imatinib Matching Placebo: Two 100 mg placebo tablets orally once a day with a meal and an 8 oz glass of water for 2 weeks. Then four 100 mg placebo tablets once a day with a meal and an 8 oz glass of water for 14 weeks. Cavosonstat Matching Placebo: 50 mg matching placebo capsule orally twice a day for 16 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Forced Expiratory Volume in One Second (FEV1) Percent PredictedTime frame: Measured at 16 weeks after the start of treatment.
- The Juniper Asthma Control Questionnaire (ACQ-6)Time frame: Measured at 16 weeks after the start of treatment.
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Scottsdale
Scottsdale, Arizona
University of Arizona Tucson
Tucson, Arizona
University of California Davis
Sacramento, California
University of California San Diego: Airway Research & Clinical Trials Center
San Diego, California
University of California San Diego: La Jolla Altman Clinical Translation Research Institute
San Diego, California
University of California San Francisco
San Francisco, California
Children's Hospital Colorado
Aurora, Colorado
University of Colorado Denver
Aurora, Colorado
National Jewish Health
Denver, Colorado
Yale University
New Haven, Connecticut
University of South Florida
Tampa, Florida
University of Illinois at Chicago
Chicago, Illinois
Ann & Robert H. Lurie Children's Hospital
Chicago, Illinois
Northwestern Universtiy
Chicago, Illinois
Rush University
Chicago, Illinois
University of Chicago
Chicago, Illinois
Riley Hospital for Children
Indianapolis, Indiana
University of Kansas
Kansas City, Kansas
Boston Children's Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Washington University
St Louis, Missouri
Mount Sinai
New York, New York
Columbia University Medical Center
New York, New York
Wake Forest University
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
University Hospitals Rainbow Babies & Children's Hospital
Cleveland, Ohio
Vanderbilt University
Nashville, Tennessee
University of Wisconsin-Madison
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.